GlobeNewswire by notified

Bulletin from the Annual General Meeting of Formpipe Software AB held 28 April 2021

Share

Due to the continued spread of the coronavirus and in order to reduce the risk of infection spreading, the meeting was conducted through postal voting, without any physical presence.

Allocation of the company’s results and discharge from liability
The Annual General Meeting (AGM) resolved, in accordance with the Board of Directors’ proposal, that SEK 0.66 per share shall be paid in dividend to the shareholders for the financial year 2020 and that the record date for the dividend shall be 30 April 2021. The dividend is expected to be distributed by Euroclear Sweden AB on 5 May 2021. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2020.

Election of Directors, Chairman of the Board, auditor and fees
The AGM resolved, in accordance with the Nomination Committee’s proposal, on the following:

That the remuneration is set to SEK 380,000 for the Chairman of the Board and SEK 190,000 each for the other members of the Board that are elected by the general meeting and are not employees in the company (i.e. a total remuneration to the Board of SEK 1,330,000).

That fees for the auditor are paid in accordance to invoice.

That the Board of Directors shall consist of six members and to re-elect Annikki Schaeferdiek, Åsa Landén Ericsson, Martin Bjäringer, Peter Lindström, Erik Syrén and Bo Nordlander as members of the Board. Bo Nordlander was re-elected as the Chairman of the Board.

To, in accordance with the Remuneration Committee’s recommendation, re-elect the auditing firm PricewaterhouseCoopers AB as the auditors of the company until the end of the AGM held in 2022. PricewaterhouseCoopers AB has announced that it intend to appoint the authorised auditor Erik Bergh as the principal auditor.

Principles for appointment of the Nomination Committee and instruction to the Nomination Committee
The AGM resolved, in accordance with the Nomination Committee’s proposal, on principles for appointment of the Nomination Committee and instruction to the Nomination Committee.

Resolution on approval of Remuneration Report
The AGM resolved to approve the Board of Directors’ Remuneration Report for 2020.

The Board’s proposal to authorise the Board to resolve on issues of shares and convertibles
The AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board to, within the limits of the articles of association, until the next AGM, on one or more occasions, resolve to issue new shares and/or convertibles. The Board is authorised to resolve on issues to the extent that the company's share capital may be increased by an amount equal to not more than 10 percent of the registered share capital at the time of the 2021 AGM.

The Board's proposal to authorise the Board to acquire and dispose of treasury shares
The AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board, for the period until the next AGM, on one or more occasions, to acquire and/or dispose of the company's shares. Purchases may be made of as many shares that the company's holding does not exceed 10 percent of all shares of the company.

The Board’s proposal regarding incentive program 2021/2024 through the issue of warrants
The AGM resolved, in accordance with the Board of Directors’ proposal, to implement incentive program 2021/2024 through a directed issue of a maximum of 500,000 warrants of series 2021/2024. Right to subscribe for the warrants shall without exemption belong to all employees of the company. Employees of the company shall be guaranteed allotment of not less than 1,800 warrants per subscriber. The warrants are issued at a price equal to market value of the warrants, calculated by using the Black & Scholes warrant valuation model. Each warrant entails a right to subscribe for one new share in the company. The subscription price when exercising a warrant shall be 120 percent of the average volume weighted price paid for the company’s share on Nasdaq Stockholm during the period from 26 April 2021 up to and including 30 April 2021. The warrants may be exercised by application for subscription for new shares during the period from and including 13 May 2024 up to and including 24 May 2024. The maximum dilution effect of incentive program 2021/2024 is estimated to approximately 0.9 percent of the total number of shares and votes in the company, provided that the warrants are fully subscribed for and exercised.

The Board’s proposal to authorise the Board to re-purchase warrants
The AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board, during the period until the next AGM, on one or more occasions, to resolve to repurchase, at the current market price, up to 50 percent of the total of 500,000 warrants issued as resolved by the AGM 2018. The warrants that are subject to the resolution, entitles its holder to subscribe for new shares in the company for SEK 17.90 per share during the period from and including 10 May 2021 up to and including 21 May 2021.

Further, the AGM resolved, in accordance with the Board of Directors’ proposal, to authorise the Board, during the period until the next AGM, on one or more occasions, to resolve to repurchase, at the current market price, up to 50 percent of the total of 500,000 warrants issued as resolved by the AGM 2019. The warrants that are subject to the resolution, entitles its holder to subscribe for new shares in the company for SEK 25.79 per share during the period from and including 9 May 2022 up to and including 20 May 2022.

A repurchase of the warrants as above shall be conditional upon each individual warrant holder who wish to have warrants repurchased using an equivalent amount of the invested warrants to subscribe for new shares.

For additional information, contact:

Christian Sundin, President and CEO of Formpipe, +46 705 67 73 85

Bo Nordlander, Chairman of the Board, +46 546 63 10

__________________________________________________________________________________________________________________

This is a translation of the original Swedish version. In the event of any discrepancies between the two versions, the original Swedish version shall take precedence.

The information was submitted for publication through the agency of the contact persons set out above, at 02.20 PM CEST April 28, 2021.

Formpipe builds valuable relationships between data and people. Driven by our core values, since 2004 we have developed premium software that provides you with the right information, in the right context, at the right time. Every time. We help over 5,500 clients worldwide to digitize and automate business processes.

Together with our customers and partners, we co-create a digital society where people thrive. We have offices in Sweden, Denmark, United Kingdom, USA and Germany. Formpipe Software is a publicly listed company on Nasdaq Stockholm.


Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Baltic Horizon Fund consolidated audited results for 202329.3.2024 10:35:00 CET | Press release

Management Board of Northern Horizon Capital AS has approved the audited financial results of Baltic Horizon Fund (the Fund) for the year 2023. The financial results remained unchanged compared to the preliminary disclosure on 15 February 2024. Executing our strategy In a challenging economic landscape characterized by inflation, interest rate volatility, and recent geopolitical events, the Fund has assessed various strategic options to navigate these complexities and ensure future growth. Over the past year, our focus has been on reshaping our strategy to foster sustainable value, concentrating efforts on avenues that promise reliable and consistent growth for our investors. In light of prevailing market conditions, we firmly believe that the execution of the ‘Modern City Life’ strategy, introduced to investors in summer 2023, is paramount to their best interests. In the coming years, we expect two thirds of the Fund’s NOI to come from the centrally located ‘Modern City Life’ multi-fu

Progress on ABN AMRO share buyback programme 22 – 28 March 202429.3.2024 08:00:00 CET | Press release

Progress on ABN AMRO share buyback programme 22 – 28 March 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 22 March 2024 up to and including 28 March 2024 a total of 3,000,000 shares and depositary receipts were repurchased at an average price of €15.47 for a total amount of €46,409,760.00. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly reports, see the ABN AMRO website at https://www.abnamro.com/en/investor-relations/information/share-buyback-programme. To date the total consideration for shares and depositary receipts repurchased amounts to €279,519,000.00 representing 55.9% of the overall share buyback programme. ABN AMRO Press Office pressrelations@nl.abnamro.com +31 20 6288900ABN AMRO Investor Relations investorrelations@nl.abnamro.com +31 20 6282282 This press release is published by ABN AMRO Ba

Public announcement in accordance with article 7:97, §4/1 of the Belgian Companies and Associations Code (“BCAC”) concerning a capital increase by contribution in kind29.3.2024 07:00:00 CET | Press release

Press release Brussels, 29 March 2024 Regulated information – Inside information Public announcement in accordance with article 7:97, §4/1 of the Belgian Companies and Associations Code (“BCAC”) concerning a capital increase by contribution in kind On 20 November 2023, Orange Belgium SA (the “Company”) received notification from Nethys SA (“Nethys”) of its wish to contribute its 25% + 1 shareholding in VOO Holding SA (“VOO”) to the capital of the Company, provided that such contribution results in Nethys holding at least 11% of the Company's share capital (after contribution), pursuant to the provisions of the shareholders' agreement entered into by and between the Company, Atlas Services Belgium SA (“ASB”) and Nethys on 2 June 2023. Nethys can be considered a “related” party to the Company within the meaning of the IAS standards, as it has significant influence over VOO within the meaning of IAS and VOO is part of the group to which the Company belongs. Date and value of the planned t

McWhorter Foundation Combats Nelson Peltz’s Outdated Ideologies and Advocates for Sustainable Inclusivity In Corporate Leadership29.3.2024 06:59:56 CET | Press release

PALM BEACH, Calif., March 29, 2024 (GLOBE NEWSWIRE) -- C.K. McWhorter, chairman of the McWhorter Foundation, voices concerns over outdated perspectives in corporate leadership, exemplified by recent remarks from Nelson Peltz regarding Disney's film direction. After encountering instances of racism and exclusivity on Town of Palm Beach Island (known as home to Jeffrey Epstein, Nelson Peltz and others), McWhorter reflects on the disconnect between elite boardroom discussions and the realities faced by diverse communities. While briefly meeting Nelson Peltz and shaking hands after both departed separate lunches, McWhorter initially respected his insights. However, recent comments made by Peltz suggesting Disney should avoid inclusive films have raised eyebrows and prompted McWhorter to speak out. "It's concerning when influential figures like Peltz advocate against inclusivity in entertainment," McWhorter comments. "The future is in diversity and representation, especially as millennial a

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates29.3.2024 05:24:27 CET | Press release

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue was approximately RMB1,503 million during 2023. The revenue from pharmaceutical products increased by approximately 58% compared to 2022. The sales revenue of TUOYI® (toripalimab) was approximately RMB919 million, representing an increase of approximately 25% compared to the previous year.Total research and development (“R&D”) expenses were approximately RMB1,937 million in 2023, representing a decrease of approximately 19% compared to 2022. The decrease in R&D expenses was mainly due to the strategic management of R&D investments in certain early-stage pipelines, while optimizing resource all

HiddenA line styled icon from Orion Icon Library.Eye